meta
|
COVID-19
Dynamic meta-analysis of evidences about drug efficacy and safety
adjuvant therapies
anti-inflammatoty and immuno-therapy
Immunosuppressants drugs
adalimumab
anakinra
anti-interleukin-6
baricitinib
baricitinib plus remdesivir
eculizumab
jakotinib
lenzilumab
ruxolitinib
tacrolimus
tetrandrine
antiviral and associated therapy
control
honey
miscellaneous
vaccines
potential COVID-19 treatments
antiviral and associated therapy
remdesivir
All
COVID-19
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 prophylaxis
infections other than COVID-19
preventing respiratory virus transmission
patient subgroup...
Studies
Meta-analysis
Excluded
Study
Exclusion reasons
Remarks
Reference(s)
Empty list - no studies excluded